Skip to main content
RUO Limitless Life Nootropics — free shipping on orders over $200 · Same-day USA dispatch.
Home Shop A-Z
Shop by Research Category
Shop by Type
Cart Checkout FAQs Contact Us Blog Call (813) 203-3466

Cagrisema Peptide

$99.00

High-purity CagriSema peptide designed for advanced dual amylin/GLP-1 receptor and metabolic regulation research. CagriSema is a fixed-dose co-formulation combining a long-acting amylin analogue with a GLP-1 receptor agonist, widely used in scientific studies exploring synergistic receptor signaling, glucose homeostasis mechanisms, and metabolic pathway dynamics in preclinical models. For Research Use Only. Not for human use.

SKU: cagrisema-5mg Category: Tags: , ,

Discount per Quantity

Quantity 5 – 9 10 +
Discount 5% 10%
Price $94.05 $89.10

Orders over $200: FREE USPS Priority shipping.

  • >99% purity — HPLC + MS verified
  • Cold-pack insulated mailers
  • Discreet US shipping (2–5 days)
  • COA available on request

Research Use Only. Not for human consumption. Sold strictly for laboratory and research use.

What is Cardiogen peptide?

CagriSema is a synthetic co-formulation widely used in preclinical research to investigate the complementary activation of amylin/calcitonin and GLP-1 receptors, prolonged half-life pharmacokinetics, receptor interaction dynamics, and multi-hormonal signaling in metabolic models. This research-grade peptide is produced under stringent GMP-compliant conditions and provided as a lyophilized powder to ensure superior purity, stability, and reliability in experimental applications.

Engineered solely for preclinical investigations, each batch of CagriSema undergoes a comprehensive quality assessment and includes complete documentation, including a Certificate of Analysis (COA), purity data, and structural verification.

Scientific Overview

CagriSema engages two pathways—amylin/calcitonin receptor agonism and GLP-1 receptor activation—in research settings. Preclinical investigations examine CagriSema’s behavior in the following areas:

  • Synergistic modulation of receptor signaling and food intake dynamics in preclinical models
  • Delay of gastric emptying and postprandial glucose response patterns
  • Insulin secretion dynamics and glucagon modulation in pancreatic models
  • Energy homeostasis signaling mechanisms in laboratory models
  • Cardiometabolic parameter modulation in metabolic study paradigms

Why Researchers Choose Our CagriSema

For laboratories requiring dependable CagriSema research peptides, our manufacturing process prioritizes reproducibility and scientific precision. Every batch is confirmed for:

  • Purity ≥99% by HPLC
  • Structural identity via mass spectrometry
  • Third-party Certificate of Analysis (COA) available per lot

For Research Use Only. Not for human use.

The FDA has not evaluated statements regarding CagriSema. This product is not intended to diagnose, treat, cure, or prevent any disease.

Explore our testing protocols in About Peptides > Rigorous Testing.

Research-Referenced Functional Attributes (Based on existing preclinical and literature data—not intended as claims of therapeutic use)

  • Complementary activation of amylin/calcitonin and GLP-1 receptors in rodent metabolic models
  • Sustained modulation of food intake signaling and gastric emptying delay via brainstem and hypothalamic pathways in preclinical studies
  • Glucose-dependent insulin secretion dynamics and glucagon modulation in pancreatic models
  • Support for investigations into synergistic receptor effects on metabolic homeostasis
  • Examination of cardiometabolic biomarker responses in high-fat diet or metabolic paradigms
  • Prolonged pharmacokinetics enabling extended receptor engagement studies in vivo

Frequently bought together

Reviews

There are no reviews yet.

Be the first to review “Cagrisema Peptide”

Your email address will not be published. Required fields are marked *